News Posts List
Renal Cell Tumors More Likely To Metastasize Better Identified By Chemical Shift MRI
04/23/2013
Adding "chemical shift" techniques to MRI can help differentiate clear cell renal cell carcinoma from other types of renal cell cancer, a new study shows. That differentiation can help physicians better determine treatment for these patients.
Treatment of metastatic RCC: What can we offer?
04/23/2013
In the newly diagnosed patient, a multimodal approach optimizes survival and quality of life.
QUESTIONS AND ANSWERS ON NRLC'S OPPOSITION TO DRUG PRICE CONTROLS
04/23/2013
Drug price controls have a devastating effect on the development of new life saving drugs.
Dr. David Samadi Blogs Weekly on Talking About Men’s Health
04/23/2013
Dr. Samadi is a board-certified urologist and an oncologist specializing in the diagnosis and treatment of urologic diseases, prostate cancer, kidney cancer...
Chemical Shift MRI Helps Differentiate Renal Cell Tumors More Likely To Metastasize
04/20/2013
Adding “chemical shift” techniques to MRI can help differentiate clear cell renal cell carcinoma from other types of renal cell cancer, a new study shows. That differentiation can help physicians better determine treatment for these patients.
National Minority Health Month Is A Call To Action
04/20/2013
That's the "dry" statement. The impact statement is that-unfortunately-for many in this country, this is more than a phrase. It's a reality that their health and their health care are in crisis. And the sooner more of us understand this, the sooner we can make a genuine effort to implement effective strategies that will address the sad state of affairs many people find themselves in when it comes to their health, and preventing and appropriately treating their diseases.
U.K. likely to pay for Avastin despite another NICE rejection
04/20/2013
Cancer drug most prescribed under separate government cancer fund.
Anti-CD70 Immunocytokines for Exploitation of Interferon-γ-Induced RIP1-Dependent Necrosis in Renal Cell Carcinoma
04/19/2013
Metastatic renal cell carcinoma (RCC) is an incurable disease in clear need of new therapeutic interventions. In early-phase clinical trials, the cytokine IFN-γ showed promise as a biotherapeutic for advanced RCC...
Why We Expect The FDA To Approve Aveo's Tivozanib
04/17/2013
A panel of cancer experts will discuss the efficacy and safety of Tivozanib and then vote for or against approval. In most cases, the FDA follows the recommendation of the ODAC panel.
Scientists ID new kidney cancer subtypes, clearing way for personalized treatment
04/17/2013
Researchers with UCLA's Institute of Urologic Oncology and department of urology have classified kidney cancer into several unique subtypes, a breakthrough that will help physicians tailor treatment to individual kidney cancer patients, moving cancer care one step closer to personalized medicine.
News Feed